PLUR — Pluri Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1158780 ·
Israel
Last close
$2.31
Market Cap
$24.92M
52W High
$3.89
52W Low
$2.22
ADV30
11,288
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 167,000 | 56,000 | -6,536,000 | -5,548,000 | 26,057,000 | 3,419,000 | 39,056,000 |
| Dec 2025 | 198,000 | 86,000 | -6,506,000 | -6,543,000 | 30,596,000 | 4,690,000 | 39,809,000 |
| Sep 2025 | 316,000 | 115,000 | -6,350,000 | -5,850,000 | 33,672,000 | 4,259,000 | 39,319,000 |
| Jun 2025 | 398,000 | 207,000 | -6,621,000 | -7,598,000 | 38,683,000 | 5,895,000 | 39,548,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-20,152,000
Investing CF
$5,304,000
Financing CF
$9,533,000
CapEx
$-1,861,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.83
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-455,448,000
Inventory
—
Receivables
$169,000
ST Investments
$7,792,000
EBIT TTM
$-26,224,000
Pretax Income TTM
$-27,129,000
Interest Exp TTM
$905,000
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,079,000
EBITDA
$-25,515,000
Free Cash Flow
$-16,613,375
Enterprise Value
$55,953,384
Total Cash
$9,322,000
Total Debt
$34,057,000
Shares Out
10,789,546
Trailing EPS
$-2.90
Book Value
$-1.78
ROE
—
ROA
-51.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Jun 2025 | 1,336,000 | -22,176,000 | -22,583,000 | 38,683,000 | 39,548,000 | — | -18,211,000 |
| Jun 2024 | 326,000 | -22,158,000 | -20,888,000 | 39,527,000 | 34,112,000 | — | -18,021,000 |
| Jun 2023 | 287,000 | -27,246,000 | -28,321,000 | 50,797,000 | 35,497,000 | — | -22,857,000 |
| Jun 2022 | 234,000 | -41,593,000 | -41,242,000 | 68,065,000 | 35,879,000 | — | -36,501,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.90
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| JSPR | Jasper Therapeutics, Inc. | $25.55M | $0.91 | — |
| QNCX | Quince Therapeutics, Inc. | $23.47M | $1.20 | — |
| DYAI | DYADIC INTERNATIONAL INC | $27.51M | $0.75 | — |
| CVM | CEL SCI CORP | $20.73M | $1.43 | — |
| SNTI | Senti Biosciences, Inc. | $30.90M | $0.99 | — |
News headlines (Yahoo Finance, 1h cache)
Pluri Secures Additional Investment from Chairman Alejandro Weinstein at 30% Premium to Market in a Private Placement
2026-03-26 12:30 · Yahoo
Pluri Secures Global IP Position with China Patent Grant for Large-Scale Immune Cell Expansion, Complementing Prior U.S. Patent
2026-02-18 13:00 · Yahoo
Pluri: Fiscal Q2 Earnings Snapshot
2026-02-12 22:12 · Yahoo
Pluri showcases cell expansion platform as Resbiomed program advances
2026-02-09 15:30 · Yahoo
Pluri Successfully Completes First Phase of Resbiomed Program for Placenta-Derived Collagen-Rich Biomaterials
2026-01-22 14:15 · Yahoo
Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved
2025-12-22 12:00 · Yahoo
A US$3.4m Market Cap Boost Pleasing ToPluri Insiders
2025-12-19 10:38 · Yahoo
Pluri Appoints Alejandro Weinstein as Chairman of the Board to Lead Strategic Shift and Unlock Value, Backed by Additional Investment
2025-12-09 13:30 · Yahoo
Pluri and Subsidiaries Earn Multiple Industry Honors, Named as Overall BioAgriculture Company of the Year
2025-11-13 13:00 · Yahoo
Pluri: Fiscal Q1 Earnings Snapshot
2025-11-12 21:55 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.